Index of reports
> Cases with Maternal Drugs Affecting Foetus (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ursodiol where reactions include maternal drugs affecting foetus. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ursodiol side effects in female
Reported by a individual with unspecified qualification from France on 2012-04-26
Patient: female
Reactions: Maternal Drugs Affecting Foetus, Dysmorphism, Caesarean Section, NO Adverse Event
Drug(s) suspected as cause:
Aspirin
Dosage: 250 mg, qd, transplacental
Indication: Foetal Exposure During Pregnancy
Josacine / 00273602 / (Josamycin Propionate)
Indication: Foetal Exposure During Pregnancy
Cellcept
Dosage: 250 mg, bid, transplacental
Indication: Foetal Exposure During Pregnancy
Innohep 1000 (Tinzaparin Sodium) Solution FOR Injection, 10000iu / .5ml
Dosage: 0.5 mg, qd, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Prograf
Dosage: 2.5 g, qd, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Pentasa
Indication: Foetal Exposure During Pregnancy
Ursodiol
Dosage: 200 mg, qid, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Calcium Carbonate
Dosage: 1 df, qd, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Prednisolone
Indication: Foetal Exposure During Pregnancy
Possible Ursodiol side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-05
Patient: female
Reactions: Congenital Nose Malformation, Maternal Drugs Affecting Foetus, Caesarean Section, Dysmorphism, Haematoma
Drug(s) suspected as cause:
Ursodiol
Dosage: 200 mg, qid, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Calcium Carbonate
Dosage: 1 df, qd, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Innohep
Dosage: 0.5 mg, qd, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Josacine / 00273602 / (Josamycin Propionate)
Dosage: transplacental
Indication: Foetal Exposure During Pregnancy
Pentasa
Dosage: transplacental
Indication: Foetal Exposure During Pregnancy
Prograf
Dosage: 2.5 g, qd, transplacental
Indication: Foetal Exposure During Pregnancy
End date: 2009-05-15
Aspirin
Dosage: 250 mg, qd, transplacental
Indication: Foetal Exposure During Pregnancy
Prednisolone
Dosage: transplacental
Indication: Foetal Exposure During Pregnancy
Cellcept
Dosage: 250 mg, bid, transplacental
Indication: Foetal Exposure During Pregnancy
Possible Ursodiol side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-09
Patient:
Reactions: LOW Birth Weight Baby, Maternal Drugs Affecting Foetus, Apgar Score LOW, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Ursodiol
Dosage: 600 mg, qd, transplacental
Indication: Foetal Exposure During Pregnancy
Glycyrrhizic Acid (Glycyrrhizic Acid)
Dosage: 60 mg, qd, unk
Indication: Foetal Exposure During Pregnancy
Prednisolone
Dosage: 60 mg, qd, transplacental, 10 mg, qd, transplacental, 25 mg, qd, transplacental
Indication: Foetal Exposure During Pregnancy
Other drugs received by patient: Magnesium Sulfate
Possible Ursodiol side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-22
Patient: 34 year old female
Reactions: Maternal Drugs Affecting Foetus, Pruritus, Anaemia, Condition Aggravated, Cholestasis, Varices Oesophageal, Premature Labour, Foetal Growth Restriction, Premature Rupture of Membranes, Post Procedural Haemorrhage, Breech Presentation, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ursodiol
|